Dow, DuPont Reach Agreement With DOJ

Posted: Updated:
Edward Breen (left) is chief executive officer of DuPont and Andrew Liveris (right) is CEO of Dow. Edward Breen (left) is chief executive officer of DuPont and Andrew Liveris (right) is CEO of Dow.

The proposed $130 billion merger of DuPont (NYSE: DD) and The Dow Chemical Co. (NYSE: DOW) has cleared another key hurdle. The companies say they have received approval from the U.S. Department of Justice's Antitrust Division which would permit the merger to move forward.

The agreement is still subject to court approval. The companies say if approval is granted, there would be no further approvals required in the U.S. for the merger to close. Both Dow and DuPont continue to expect the deal to close in August.

The agreement includes a previously-announced decision for DuPont to divest a portion of its crop protection business, while Dow will divest its global Ethylene Acrylic Acid copolymers and ionomers business. The divestitures are already part of commitments made to obtain regulatory clearance in Europe.

"We are very pleased that the DOJ has approved this transaction," said Andrew Liveris, chairman and chief executive officer of Dow. "With today's DOJ clearance, we have taken a significant step forward in bringing together these two iconic enterprises, and in the subsequent intended separation into three leading, independent innovation-based science companies that will generate significant benefits for all stakeholders."

Once the merger closes, the newly-named DowDuPont will spin out into three independent, publicly-traded companies, including a $18 billion agriculture spinoff that will have a major presence at the current Dow Agrosciences facility in Indianapolis. The spin-offs are expected to take place within 18 months of the merger closing.

Last month, the companies announced the members of what will be the DowDuPont Board of Directors.

  • Perspectives

    • Jeff Rea serves as CEO and president of the South Bend Regional Chamber of Commerce.

      IDEA Week Offers Something For Everyone

      South by Southwest wrapped up over the weekend in Austin. The week-long event was launched to bring people together to meet, learn and share ideas and it features sessions, showcases, screenings, exhibitions, and a variety of networking opportunities. Music and film, and the entertainment industry were the main drivers but over the years the event has grown into so much more. Events like SXSW have served as inspiration for a new event to be offered this spring, IDEA Week 2018.



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • Danny Lopez currently serves as deputy chief of staff under Holcomb.

      Holcomb Names Governor's Workforce Council Chair

      Governor Eric Holcomb has made some leadership changes within his administration. The governor has selected Danny Lopez, who currently serves as his deputy chief of staff, as chairman of the new Governor's Workforce Council.

    • Derica Rice Joining CVS

      The former chief financial officer of Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has been named president of CVS Caremark. Derica Rice, who spent 27 years with Lilly, will take the helm of CVS Health Corp.'s (NYSE: CVS) pharmacy benefit management business next week. Rice's experience at Lilly included roles as...

    • Job Skills Programs Land Millions

      More than a dozen organizations will share over $11 million in Skill UP Indiana! grants. The Indiana Department of Workforce Development says the funding will support efforts to equip Hoosiers with necessary skills to fill a projected one million job openings over the next decade.

    • Indiana Businesses Shuffle on Fortune 500

      Seven Hoosier-based corporations are among the 500 largest in the country. Indiana gained two Fortune 500 companies and lost one on this year's list.

    • Mainstreet Adds to Team

      Carmel-based Mainstreet has named Jeff Key vice president of business development. Most recently, he served as vice president of the US healthcare systems team at The Medicines Co. The firm has also named Scott Roberts director of strategic projects, business development. He previously served as manager of strategy and product development at TriMedx. Roberts also spent time at Franciscan St. Francis Health.